MedPath

Diflorasone Diacetate

Diflorasone Diacetate Ointment USP, 0.05%

Approved
Approval ID

b304dfca-e840-4c03-8217-73aaa5360277

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 27, 2020

Manufacturers
FDA

Taro Pharmaceuticals U.S.A., Inc.

DUNS: 145186370

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Diflorasone Diacetate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51672-1295
Application NumberANDA075331
Product Classification
M
Marketing Category
C73584
G
Generic Name
Diflorasone Diacetate
Product Specifications
Route of AdministrationTOPICAL
Effective DateJanuary 27, 2020
FDA Product Classification

INGREDIENTS (4)

Diflorasone DiacetateActive
Quantity: 0.5 mg in 1 g
Code: 7W2J09SCWX
Classification: ACTIB
petrolatumInactive
Code: 4T6H12BN9U
Classification: IACT
propylene glycolInactive
Code: 6DC9Q167V3
Classification: IACT
glyceryl monostearateInactive
Code: 230OU9XXE4
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Diflorasone Diacetate - FDA Drug Approval Details